News Release

Undiagnosed major risk factors found in two thirds of ischaemic stroke patients, new study reveals

People who suffer from ischaemic strokes with no previously diagnosed risk factors have been found to have underlying conditions in the majority of cases

Reports and Proceedings


(Vienna, Sunday, 26 June, 2022) People who suffer from ischaemic strokes with no previously diagnosed risk factors have been found to have underlying conditions in the majority of cases, a new study presented today at the European Academy of Neurology (EAN) Congress 2022 has shown.1

Overall, the study identified 67.7% of stroke patients with previously undiagnosed major risk factors (UMRF) were found to have one major risk factor.

Researchers from the Centre Vaudois, Lausanne, Switzerland, analysed health records of 4,354 stroke patients from the ASTRAL registry from 2003 to 2018, 1,125 of whom had UMRF.

The most common detected vascular risk factor was dyslipidaemia, an imbalance of blood fats such as high cholesterol or raised levels of triglycerides (61.4% of patients). The second most common risk factor was high blood pressure (23.7% of patients), and one in 10 (10.2% of patients) patients had atrial fibrillation, a condition which causes a fast and often irregular heartbeat.

Using multivariate analyses, the research found a positive association between UMRF patients and lower age, non-Caucasian ethnicity, contraceptive use in women aged under 55 and smoking for patients 55 and older. The research also found negative associations with antiplatelet (blood thinner) use before the stroke and higher Body Mass Index (BMI).

Ischaemic stroke occurs when a blood clot or other blockage cuts off bloody supply to the brain and is the most common type of stroke.

Lead author Dr André Rêgo said the study provides important insights on major risk factors for ischaemic stroke.

“Our findings underline the importance of testing and treating blood fat imbalances such as high cholesterol and triglyceride levels, as well as blood pressure and identifying and treating those with atrial fibrillation and type 2 diabetes”, commented Dr Rêgo.

“Prior to our study there was scarce clinical information about the frequency, patient profile and stroke mechanisms in patients with acute ischaemic stroke with previously undiagnosed major vascular risk factors. We hope that this study will help to identify potential stroke patients that require more intensive prevention techniques and surveillance in the future.”



Notes to Editors:

Press Enquiries:

A reference to the EAN Congress 2022 must be included when communicating the information within this press release.

For further information or to speak to an expert, please contact Luke Paskins or Sean Deans at or call +44 (0) 208 154 6393

About the Expert:

Dr André Rêgo is currently based at the Centre Vaudois, Lausanne, Switzerland, and is from the Fernando Fonseca Hospital in Portugal.

EAN – The Home of Neurology:

The European Academy of Neurology (EAN) is Europe’s home of neurology. Founded in 2014, through the merger of two European neurological societies, EAN represents the interests of more than 45,000 individual members and 47 national institutional members from across the continent.

EAN welcomes the interest of press in neurological issues and provides assistance to journalists attending the congress or using the EAN website as a resource in their coverage, with pleasure.


  1. Undiagnosed major risk factors in patients with acute ischaemic stroke: clinical profile, stroke mechanisms and outcome, presented at the EAN Congress 2022.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.